EUVIMEDEUVIMED entdecken
MetaanalyseKohortenstudieOpen Access · CC BY 4.0

Microangiopathy associated with poor outcome of immunoglobulin A nephropathy: a cohort study and meta-analysis

Lei Dong, Yuncan Hu, Dan Yang, Liu Liu, Yueqiang Li, Shuwang Ge iD, Ying Yao

Clinical Kidney Journal · 01.02.2024 · 17 (2)

DOI: 10.1093/ckj/sfae012 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Clinical Kidney Journal, online erschienen am 24.01.2024. Verfasst von Lei Dong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Hubei Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Microangiopathy (MA) lesions are not rare in immunoglobulin A nephropathy (IgAN) and have been suggested to have a potential role in increasing risk in renal function decline. However, this suggestion has not been universally accepted. We aimed to investigate its role in our cohort and in multiple studies through a systematic meta-analysis.

Methods

This cohort study included 450 IgAN patients, confirmed by renal biopsy, at Tongji Hospital, China, from January 2012 to December 2016. Clinical data were collected and analysed. We systematically searched PubMed and Web of Science for studies investigating the association between MA lesions and IgAN.

Results

In our cohort, IgAN patients with MA were significantly older and had higher blood pressure, more proteinuria, worse kidney function and increased uric acid levels compared with patients without MA. When comparing pathological features with the non-MA group, the MA group exhibited more global glomerulosclerosis and interstitial fibrosis/tubular atrophy. MA lesions were independently associated with a composite kidney outcome in IgAN patients {adjusted hazard ratio 2.115 [95% confidence interval (CI) 1.035–4.320], P = .040}. Furthermore, this relationship was validated in a meta-analysis involving 2098 individuals from five independent cohorts. The combined data showed a 187% adjusted risk of poor renal outcome in IgAN patients with MA compared with patients without MA [adjusted risk ratio 2.87 (95% CI 2.05–4.02; I2 = 53%).

Conclusion

MA lesions could serve as a valuable predictor for disease progression in patients with IgAN, extending beyond the widely recognized Oxford MEST-C score.

Schlagwörter

Stichwörter der Autor:innen

IgA nephropathycohort studymeta-analysismicroangiopathyoutcome

Autor:innen und Institutionen

  • Division of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Division of Nephrology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China.

ORCID-Profile: Shuwang Ge

Förderung

  • National Natural Science Foundation of China
  • Hubei Provincial Natural Science Foundation

Zitieren

APA

Dong, L., Hu, Y., Yang, D., Liu, L., Li, Y., Ge, S., & Yao, Y. (2024). Microangiopathy associated with poor outcome of immunoglobulin A nephropathy: a cohort study and meta-analysis. Clinical Kidney Journal, 17(2). https://doi.org/10.1093/ckj/sfae012

Vancouver

Dong L, Hu Y, Yang D, Liu L, Li Y, Ge S, et al. Microangiopathy associated with poor outcome of immunoglobulin A nephropathy: a cohort study and meta-analysis. Clinical Kidney Journal. 2024;17(2). doi:10.1093/ckj/sfae012

BibTeX
@article{Dong2024,
  author = {Dong, Lei and Hu, Yuncan and Yang, Dan and Liu, Liu and Li, Yueqiang and Ge, Shuwang and Yao, Ying},
  title = {Microangiopathy associated with poor outcome of immunoglobulin A nephropathy: a cohort study and meta-analysis},
  journal = {Clinical Kidney Journal},
  year = {2024},
  volume = {17},
  number = {2},
  doi = {10.1093/ckj/sfae012}
}
Kostenlos starten →